Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam eu turpis molestie, dictum est a, mattis tellus. Sed dignissim, metus nec fringilla accumsan, risus sem sollicitudin lacus, ut interdum tellus elit sed risus. Maecenas eget condimentum velit, sit amet feugiat lectus. Class aptent taciti sociosqu ad litora torquent per conubia nostra, per inceptos himenaeos. Praesent auctor purus luctus enim egestas, ac scelerisque ante pulvinar. Donec ut rhoncus ex. Suspendisse ac rhoncus nisl, eu tempor urna. Curabitur vel bibendum lorem. Morbi convallis convallis diam sit amet lacinia. Aliquam in elementum tellus.
Established in 2019, CannDo Pharma is a division of Atlanta Medicare that has been set up to focus on the growing cannabis market. The changing regulations in Thailand, promoting the growth of cannabis, have also played a part in
the genesis of CannDo Pharma.
We have partnered up with Chiang Mai University (CMU) to grow cannabis for medical purposes in an indoor facility in
Chiang Mai. The production of medicinal cannabis requires medical grade raw materials that are of the same genetics,
consistency, high-quality and having the right THC:CBD proportion. We intend to produce pure CBD and THC crystals that can be made into oils.
Given the novelty of the cannabis industry in Asia Pacific, we aspire to grow and be one of the market leaders by
producing high-quality products that can make a difference in the long-term health and welfare of the Thai Population.
